DOCS Dr. Martens plc

0.7177USD54.50 GBp · LSE-2.85%Mkt Cap: 682.16M USDP/E: 18.17

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Amer…

Institutional holders10 on file

Key Statistics

Company
Market Cap682.16M USD
Enterprise Value1.11B USD
Revenue (TTM)965.64M USD
Gross Profit666.32M USD
Net Income (TTM)31.34M USD
Revenue/Share1.00 USD
Last Price0.7177 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees3.6K
CountryGB
SectorConsumer Cyclical
IndustryFootwear & Accessories
ISINGB00BL6NGV24
Valuation
P/E (Trailing)18.17
P/E (Forward)10.82
PEG0.83
EV/EBITDA10.66
EV/Revenue1.15
P/S0.71
P/B1.58
EPS (TTM)0.04 USD
EPS (Forward)0.07 USD
52W Range
0.000060% of range1.190
52W High1.190 USD
52W Low0.0000 USD
Profitability
Gross Margin66.15%
Oper. Margin9.07%
EBITDA Margin10.79%
Profit Margin3.11%
ROE6.58%
ROA2.71%
ROIC7.64%
ROCE8.41%
Growth
Revenue Growth-9.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF187.91M USD
CapEx (TTM)15.67M USD
FCF Margin10.59%
FCF Yield14.99%
Net Debt407.96M USD
Net Debt/EBITDA3.92
Net Debt/FCF3.99
Balance Sheet
Debt/Equity1.09
Current Ratio2.34
Quick Ratio1.11
Book Value/Sh0.46 USD
Cash/Share0.13 USD
Dividends
Fwd Div Rate0.0004 USD
Trail. Div Rate0.0003 USD
Div. Yield4.55%
5Y Avg Yield2.30%
Payout Ratio91.07%
Ex-Div DateMar 4, 2027
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.093 USD
Upside (mean)+52.3%
Target Range0.7506 USD – 1.857 USD
0.7506+52.3% to mean1.857
# Analysts6
Ownership
Shares Out.950.51M
Float488.51M
Insiders41.80%
Institutions41.10%
Technical
SMA 500.8686 (-17.4%)
SMA 2000.9117 (-21.3%)
Beta0.34
S&P 52W Chg12.08%
Avg Vol (30d)2.25M
Avg Vol (10d)3.64M
Technical Indicators
RSI (14)26.9
MACD-3.4088
MACD Signal-2.5902
MACD Hist.-0.8186
BB Upper0.9469 USD
BB Middle0.8143 USD
BB Lower0.6818 USD
BB Width32.56%
ATR (14)0.0464 USD
Vol Ratio (20d)1.39x

About Dr. Martens (LON: DOCS)

›

Dr. Martens (LON: DOCS) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Footwear & Accessories industry, part of the Consumer Cyclical sector, and reports about 3,600 employees.

The shares were at 54.50 GBp on 19 November 2026, down 36.8% over 52 weeks.

At a market capitalisation of 518.03M GBP, it trades at 18.2 times trailing earnings and 10.8 times forward earnings. The median trailing P/E of its 15 largest Footwear & Accessories peers is 12.7, a premium of 43% for DOCS. It pays a dividend yielding 4.55% (it pays out 91% of its earnings), against a median of 2.54% among the dividend payers in that peer group.

Dr. Martens reports return on equity of 6.6%, an operating margin of 9.1% and revenue down 9.8% year over year.

Its debt exceeds its cash by 309.80M GBP, a debt-to-equity ratio of 1.09. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 83.00 GBp is 52.3% above the current price. The next earnings report is expected on 19 November 2026.